Cargando…
CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut Injury
Mesenchymal stromal cell (MSC)-based therapy for inflammatory diseases involves paracrine and efferocytotic activation of immunosuppressive interleukin-10(+) (IL-10(+)) macrophages. The paracrine pathway for MSC-mediated IL-10(+) macrophage functionality and response to tissue injury is not fully un...
Autores principales: | Giri, Jayeeta, Das, Rahul, Nylen, Emily, Chinnadurai, Raghavan, Galipeau, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043065/ https://www.ncbi.nlm.nih.gov/pubmed/32049021 http://dx.doi.org/10.1016/j.celrep.2020.01.047 |
Ejemplares similares
-
A STAT5-Smad3 dyad regulates adipogenic plasticity of visceral adipose mesenchymal stromal cells during chronic inflammation
por: Das, Rahul, et al.
Publicado: (2022) -
Macrophages at the nexus of mesenchymal stromal cell potency: The emerging role of chemokine cooperativity
por: Galipeau, Jacques
Publicado: (2021) -
The IDO inhibitor 1-methyl tryptophan activates the aryl hydrocarbon receptor response in mesenchymal stromal cells
por: Lewis, Holly C., et al.
Publicado: (2017) -
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
por: Stenger, Elizabeth, et al.
Publicado: (2022) -
CCL2-Mediated Stromal Interactions Drive Macrophage Polarization to Increase Breast Tumorigenesis
por: Archer, Maddison, et al.
Publicado: (2023)